Vegas Lawyer



Vegas Lawyer

(702) 388-1229



Nevada Injury Law

Wrongful Death | Car Accident | Slip & Fall | Malpractice | Product Defect | Other Claims

Las Vegas Inury Lawyer
Las Vegas Injury Lawyer





Las Vegas Injury Lawyer

MDI and DPI Drug Products
...The guidance sets forth information that should be provided to ensure continuing drug.....recommended for inclusion in the application regarding the components, manufacturing.....establish a set of criteria to which a drug substance or drug product should conform using..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=100)

WAIS Document Retrieval
...For the impurity test, the discrimination may be established by spiking drug substance or drug product with.....For critical separations, specificity can be demonstrated by the resolution of the two.....drug product components, it may be acceptable either to add known quantities of the analyte to..
http://www.fda.gov/cder/guidance/ichq2b.htm (score=93)

J:!GUIDANCFINALICHQ2B.PDF
...the drug product or to compare the results obtained from a second, well-characterized procedure.....demonstrate specificity, and individual components should be appropriately labeled.....solution) and/or separate weighings of synthetic mixtures of the drug product components, using..
http://www.fda.gov/cder/guidance/1320fnl.pdf (score=93)

Jurisdictional Update: Drug-Biologic Combination Products
...For drug-biologic combination products where both the drug and biological product components are regulated by CDER.....FDA recommends that questions about the assignment of a drug-biologic combination product to a reviewing division.....drug-biologic combination products where both the drug and biological product components..
http://www.fda.gov/oc/combination/biologic.html (score=88)

Guidance for Industry
...products shall be excluded from direct contact with components, drug product containers, closures, in.....specifications, standards, sampling plans, and test procedures designed to assure that components, drug.....the acceptance of each lot within each shipment of components, drug product containers, closures, and..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=76)

Sterile Drug Products Produced by Aseptic Processing
...Drug product components, containers, closures, storage time limitations, and manufacturing equipment.....Components and drug product containers and closures shall at all times be handled and stored in a manner to.....Drug product containers and closures shall be clean and, where indicated by the nature of the..
http://www.fda.gov/cder/guidance/5882fnl.htm (score=70)

Guidance for Industry
...products shall be excluded from direct contact with components, drug product containers, closures, in.....specifications, standards, sampling plans, and test procedures designed to assure that components, drug.....the acceptance of each lot within each shipment of components, drug product containers, closures, and..
http://www.fda.gov/cder/guidance/1874dft.pdf (score=70)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...ensure that each batch of PET drug product meets its established acceptance criteria, 1201.....evaluation can include testing of the material (see Section VI, Control of Components, 276.....or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=53)

Guidance for Industry
...1 This guidance was prepared by the Office of Pharmaceutical Science in the Center for.....Manufacturers should contact the appropriate CBER product office to discuss the.....This draft guidance, when finalized, will represent the Food and Drug Administration's..
http://www.fda.gov/OHRMS/DOCKETS/98fr/5815dft.pdf (score=50)


...The chemical, physical, and biopharmaceutic characteristics of a drug 3. The selection of product components and packaging.....Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and.....In addition, developing and implementing innovative tools for a particular product does..
http://www.fda.gov/cder/guidance/5815dft.doc (score=50)

PAT — A Framework for Innovative Pharmaceutical Development,...
...Within this scope, the guidance is applicable to all manufacturers of drug substances, drug products, and.....In addition, developing and implementing an innovative PAT system for a particular product.....chemical separation to isolate it from other components). During sample preparation, other..
http://www.fda.gov/cder/guidance/6419fnl.htm (score=49)

Guidance for Industry: Q2B Validation of Analytical Procedures: Methodology
...the drug product or to compare the results obtained from a second, well-characterized procedure.....demonstrate specificity, and individual components should be appropriately labeled.....solution) and/or separate weighings of synthetic mixtures of the drug product components, using..
http://www.fda.gov/cber/gdlns/ichq2bmeth.pdf (score=47)

Guidance for Industry: Drug Product: Chemistry, Manufacturing, and Controls...
...However, information on other components of the drug product should also be included in section P.4, as.....Components used in the manufacture of the drug product, regardless of whether or not they appear in the finished drug product.....The composition statement must contain a list of all components used in the manufacture of the drug product regardless of whether or..
http://www.fda.gov/cber/gdlns/drugcmc.htm (score=44)

ICH; Draft Guidance on Q8 Pharmaceutical Development
...The knowledge gained from the studies investigating the potential effect of drug substance properties on drug product.....This summary should also take into consideration the choice of drug product components, (e.....Any overages in the manufacture of the drug product, whether they appear in the final..
http://www.fda.gov/cber/gdlns/ichq8pharm.htm (score=40)


...1 Components of the Drug Product 5 2.1.1 Drug Substance 5 2.1.2 Excipients 5 2.2 Drug Product 6 2.2.1 Formulation.....1 Components of the Drug Product 2.1.1 Drug Substance The physicochemical and biological properties of the drug.....The knowledge gained from the studies investigating the potential effect of drug substance properties on drug product..
http://www.fda.gov/cder/guidance/6672dft.doc (score=40)

FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...2 The manipulation of a sterile drug product may contaminate it, especially when nonsterile.....For these reasons, the drug formulation of a TDS product, including the interaction of all TDS components, is highly.....To qualify for these statutory exemptions, a compounded drug product must satisfy several..
http://www.fda.gov/cder/fdama/difconc.htm (score=38)

6672dft.doc
...identification of those attributes that are critical to the quality of the drug product, taking.....functionality, and to perform throughout the intended drug product shelf life, should also.....choice of drug product components, (e.g. the properties of the drug substance, excipients..
http://www.fda.gov/cder/guidance/6672dft.pdf (score=37)

International Conference on Harmonisation; Draft Guidance on Q8...
...identification of those attributes that are critical to the quality of the drug product, taking.....functionality, and to perform throughout the intended drug product shelf life, should also.....choice of drug product components, (e.g. the properties of the drug substance, excipients..
http://www.fda.gov/cber/gdlns/ichq8pharm.pdf (score=37)

Q8 Pharmaceutical Development
...The knowledge gained from the studies investigating the potential effect of drug substance properties on drug product.....This summary should also take into consideration the choice of drug product components, (e.....Chemical Substances describes some of the circumstances in which drug product studies are..
http://www.fda.gov/cder/guidance/6672.dft.htm (score=35)

Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products...
...The performance of the valve and its compatibility with other drug product components should be.....Furthermore, modification or alteration of these products due to changes in components of the drug product or.....The drug product should be evaluated for compounds that leach from elastomeric, plastic..
http://www.fda.gov/CDER/GUIDANCE/2180dft.htm (score=30)

Powered by viXML, providing custom search results

Las Vegas Injury Lawyer




Read this important disclaimer

Information on Las Vegas Injury Lawyer.

If you experience unusual problems with this site please email the webmaster.

Copyright: David Matheny, 2005-2008.